The C. elegans
hif-1 gene is orthologous to the mammalian hypoxia inducible factor alpha units, which have been described as master regulators of transcriptional response to hypoxia (low oxygen). Mutants lacking
hif-1 function are viable in normoxic conditions, but they cannot adapt to hypoxia (Jiang et al. 2001, PNAS 98: 7916). The stability of the HIF-1 protein is regulated by the evolutionarily conserved EGL-9/ VHL-1 pathway. In normoxia, a proline in the oxygen-dependent degradation domain of HIF-1 is hydroxylated by EGL-9, enabling HIF-1 to bind VHL-1. VHL-1 targets HIF-1 for degradation (Epstein et al. 2001, Cell 107: 43). To further understand the role of HIF-1 in hypoxia response, we compared the mRNA expression patterns of wild-type,
hif-1-deficient, and
vhl-1-deficient animals in normoxic and in hypoxic conditions using microarray technology. We identified over 100 genes that exhibit a >2-fold difference in mRNA expression in hypoxic conditions (p < 0.05). The majority of these genes are regulated in a
hif-1-dependent manner. We hypothesized that some of the transcriptional targets of HIF-1 might also be required for survival of hypoxia. To test this, we used mutation or RNAi to deplete gene function and assayed viability in normoxia and hypoxia. We report that several individual HIF-1 target genes have essential roles in adaptation to hypoxia. We aim to use genetic methods to identify VHL-independent regulators of HIF-1 and to isolate additional alleles of HIF-1. In pilot screens, we have identified several mutations that alter the expression of HIF-1 target genes. One of these mutations results in a constitutively expressed, truncated HIF-1 protein. The other mutations map to other regions of the genome. We are working towards identification and characterization of these potential HIF-1 regulators. This project is supported by the American Heart Association.